These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21422221)

  • 1. Loss of heterozygosity of FCY2 leading to the development of flucytosine resistance in Candida tropicalis.
    Chen YN; Lo HJ; Wu CC; Ko HC; Chang TP; Yang YL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2506-14. PubMed ID: 21422221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.
    Chapeland-Leclerc F; Bouchoux J; Goumar A; Chastin C; Villard J; Noël T
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3101-8. PubMed ID: 16048910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.
    Florent M; Noël T; Ruprich-Robert G; Da Silva B; Fitton-Ouhabi V; Chastin C; Papon N; Chapeland-Leclerc F
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2982-90. PubMed ID: 19414575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France.
    Desnos-Ollivier M; Bretagne S; Bernède C; Robert V; Raoux D; Chachaty E; Forget E; Lacroix C; Dromer F;
    Emerg Infect Dis; 2008 Apr; 14(4):557-65. PubMed ID: 18394272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast.
    Paluszynski JP; Klassen R; Meinhardt F
    Microbiology (Reading); 2008 Oct; 154(Pt 10):3154-3164. PubMed ID: 18832321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006.
    Li SY; Yang YL; Lin YH; Ko HC; Wang AH; Chen KW; Wang CW; Chi H; Lo HJ;
    Microb Drug Resist; 2009 Sep; 15(3):205-10. PubMed ID: 19728779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter.
    Noël T; François F; Paumard P; Chastin C; Brèthes D; Villard J
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1275-84. PubMed ID: 12654658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.
    McManus BA; Moran GP; Higgins JA; Sullivan DJ; Coleman DC
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4678-85. PubMed ID: 19704126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway.
    Vu K; Thompson GR; Roe CC; Sykes JE; Dreibe EM; Lockhart SR; Meyer W; Engelthaler DM; Gelli A
    Med Mycol; 2018 Oct; 56(7):857-867. PubMed ID: 29554336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.
    Dodgson AR; Dodgson KJ; Pujol C; Pfaller MA; Soll DR
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2223-7. PubMed ID: 15155225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of flucytosine resistance in Candida glabrata.
    Edlind TD; Katiyar SK
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4733-8. PubMed ID: 20823283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.
    Papon N; Noël T; Florent M; Gibot-Leclerc S; Jean D; Chastin C; Villard J; Chapeland-Leclerc F
    Antimicrob Agents Chemother; 2007 Jan; 51(1):369-71. PubMed ID: 17060521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
    Pai MP; Samples ML; Mercier RC; Spilde MN
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2367-76. PubMed ID: 18426896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole.
    Yang YL; Lin CC; Chang TP; Lauderdale TL; Chen HT; Lee CF; Hsieh CW; Chen PC; Lo HJ
    PLoS One; 2012; 7(4):e34609. PubMed ID: 22496832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
    Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
    Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flucytosine primary resistance in Candida species and Cryptococcus neoformans.
    Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Rodríguez-Tudela JL
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):276-9. PubMed ID: 11399020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.
    Pfaller MA; Messer SA; Boyken L; Huynh H; Hollis RJ; Diekema DJ
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3518-21. PubMed ID: 12384359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
    Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
    BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic relatedness among azole-resistant Candida tropicalis clinical strains in Taiwan from 2014 to 2018.
    Zhou ZL; Tseng KY; Chen YZ; Tsai DJ; Wu CJ; Chen YC; Peng HL; Yang YL; Hsieh LY; Chen CH; Hsu CH; Wang LS; Cheng MF; Hsu GJ; Kao CC; Hu BS; Lee YT; Liu JW; Liu KS; Miu WC; Yang HM; Yeh YC; Lo HJ
    Int J Antimicrob Agents; 2022 Jun; 59(6):106592. PubMed ID: 35460852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.